Axillary concordance between superficial and deep sentinel node mapping material injections in breast cancer patients: systematic review and meta-analysis of the literature Ramin SadeghiMehdi AsadiDavid N. Krag Review 13 February 2014 Pages: 213 - 222
The value of platinum agents as neoadjuvant chemotherapy in triple-negative breast cancers: a systematic review and meta-analysis Fausto PetrelliAndrea CoinuSandro Barni Review 21 February 2014 Pages: 223 - 232
Expert perspectives on biosimilar monoclonal antibodies in breast cancer J. CortésG. CuriglianoV. Diéras Review Open access 23 February 2014 Pages: 233 - 239
Early changes in [18F]FDG incorporation by breast cancer cells treated with trastuzumab in normoxic conditions: role of the Akt-pathway, glucose transport and HIF-1α Ian N. FlemingAlexandra AndriuTim A. D. Smith Preclinical study 13 February 2014 Pages: 241 - 248
Differential expression of progesterone receptor, FOXA1, GATA3, and p53 between pre- and postmenopausal women with estrogen receptor-positive breast cancer Mitsuchika HosodaMitsugu YamamotoHiroko Yamashita Preclinical study 19 February 2014 Pages: 249 - 261
Therapeutic potential of the dual EGFR/HER2 inhibitor AZD8931 in circumventing endocrine resistance Gladys MorrisonXiaoyong FuRachel Schiff Preclinical Study 20 February 2014 Pages: 263 - 272
Characterisation of HER heterodimers in breast cancer using in situ proximity ligation assay FabrĂcio F. T. BarrosTarek M. A. Abdel-FatahAndrew R. Green Preclinical Study 21 February 2014 Pages: 273 - 285
mTORC1/C2 and pan-HDAC inhibitors synergistically impair breast cancer growth by convergent AKT and polysome inhibiting mechanisms Kathleen A. Wilson-EdellMariya A. YevtushenkoChristopher C. Benz Preclinical study 22 February 2014 Pages: 287 - 298
Dermcidin expression is associated with disease progression and survival among breast cancer patients Heather Ann BrauerMonica D’ArcyPaul D. Lampe Preclinical study 22 February 2014 Pages: 299 - 306
Benefit from anthracyclines in relation to biological profiles in early breast cancer Andrea RoccaSara BravacciniDino Amadori Clinical Trial 01 January 2014 Pages: 307 - 318
Erratum to: Benefit from anthracyclines in relation to biological profiles in early breast cancer Andrea RoccaSara BravacciniDino Amadori Erratum 19 February 2014 Pages: 319 - 319
Bone mineral density and circulating biomarkers in the BIG 1-98 trial comparing adjuvant letrozole, tamoxifen and their sequences Andrea DeCensiZhuoxin SunStefan Aebi Clinical trial 01 February 2014 Pages: 321 - 329
Assessment of microtubule-associated protein (MAP)-Tau expression as a predictive and prognostic marker in TACT; a trial assessing substitution of sequential docetaxel for FEC as adjuvant chemotherapy for early breast cancer S. IrshadC. GillettA. Tutt Clinical Trial 12 February 2014 Pages: 331 - 341
Effect of adjuvant endocrine therapy on hormonal levels in premenopausal women with breast cancer: the ProBONE II study Peyman HadjiAnnette KaukaPeter Kann Clinical Trial 12 February 2014 Pages: 343 - 351
Disseminated tumor cells as a monitoring tool for adjuvant therapy in patients with primary breast cancer Ines GruberTanja FehmAndreas Daniel Hartkopf Clinical trial 20 February 2014 Pages: 353 - 360
Effects of exercise dose and type on sleep quality in breast cancer patients receiving chemotherapy: a multicenter randomized trial Kerry S. CourneyaRoanne J. SegalDonald C. McKenzie Clinical trial 20 February 2014 Pages: 361 - 369
Application of a decision analytic framework for adoption of clinical trial results: are the data regarding TARGIT-A IORT ready for prime time? L. J. EssermanM. D. AlvaradoE. M. Ozanne Clinical trial Open access 02 March 2014 Pages: 371 - 378
Determinants of genetic counseling uptake and its impact on breast cancer outcome: a population-based study Aurélie AymeValeria ViassoloSimone Benhamou Epidemiology 12 February 2014 Pages: 379 - 389
The value of substratified combined imaging assessment with mammography and ultrasonography for Chinese women with palpable breast masses Jiguang LiPeng XingXinyu Zheng Epidemiology 12 February 2014 Pages: 391 - 396
Survival from breast cancer in patients with CHEK2 mutations T. HuzarskiC. CybulskiS. A. Narod Epidemiology 21 February 2014 Pages: 397 - 403
Comparative safety of cardiovascular medication use and breast cancer outcomes among women with early stage breast cancer Denise M. BoudreauOnchee YuDiana S. M. Buist Epidemiology 21 February 2014 Pages: 405 - 416
First do no harm: population-based study shows non-evidence-based trastuzumab prescription may harm elderly women with breast cancer Ya-Chen Tina ShihYing XuYu Shen Epidemiology 21 February 2014 Pages: 417 - 425
Digoxin use and risk of invasive breast cancer: evidence from the Nurses’ Health Study and meta-analysis Thomas P. AhernRulla M. TamimiSusan E. Hankinson Epidemiology 28 February 2014 Pages: 427 - 435
Evaluation of the RHINO gene for breast cancer predisposition in Finnish breast cancer families Tuomas HeikkinenSofia KhanHeli Nevanlinna Brief Report 22 February 2014 Pages: 437 - 441
